Today: 8 June 2026
Browse Category

NYSE:ABT 7 July 2025 - 20 November 2025

Abbott to Acquire Exact Sciences for $21 Billion in Cancer Screening Mega-Deal

Abbott to Acquire Exact Sciences for $21 Billion in Cancer Screening Mega-Deal

Abbott will acquire Exact Sciences for $105 per share in cash, valuing the deal at about $23 billion including debt. The boards of both companies approved the transaction, which is set to close in the second quarter of 2026 pending shareholder and regulatory approval. Exact Sciences will become a subsidiary, expanding Abbott’s diagnostics revenue and portfolio. The offer represents a 21–22% premium to Exact’s last closing price.
20 November 2025
··
Abbott (ABT) Stock Slides on Mixed Q3 Results – Is a Rally Over?

Abbott Nears Takeover of Exact Sciences, Sending Cancer Test Maker’s Stock Soaring on November 19, 2025

Abbott Laboratories is in advanced talks to acquire Exact Sciences, sources told Bloomberg on Wednesday, in what would be Abbott’s largest deal since 2016. Exact Sciences shares surged up to 29% intraday, reaching a market value near $16 billion, while Abbott stock fell around 3%. No official comments have been made by either company.
19 November 2025
···
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 20.10.2025

Fed Chair Jerome Powell signaled the central bank may soon pause its balance-sheet runoff, hinting at an end to quantitative tightening. The move could ease monetary conditions and support stocks, though risks remain if earnings weaken. AbbVie and Abbott Laboratories continue to deliver steady dividend growth, appealing to long-term income investors. Walmart’s new OpenAI partnership and AI-driven features have lifted its shares despite sector headwinds.
20 October 2025
···
Abbott (ABT) Stock Slides on Mixed Q3 Results – Is a Rally Over?

Abbott (ABT) Stock Slides on Mixed Q3 Results – Is a Rally Over?

ABT shares closed at $128 on Oct. 15, down 3.5% for the day and about 2% for the week. Abbott reported Q3 revenue of $11.37 billion, up 6.9% year-over-year but slightly below estimates; adjusted EPS matched forecasts at $1.30. Medical Devices drove growth, while Diagnostics fell 6.6%. Investors sold off the stock after in-line results, with analysts maintaining a Hold rating and a $143.50 median price target.
15 October 2025
··
Global Wearable Health Tech News – June and July 2025

Global Wearable Health Tech News – June and July 2025

Biobeat’s cuffless vital-sign patch received FDA clearance and CE marking for remote hospital monitoring. PharmaSens and SiBionics unveiled the niia™ signature patch, combining a continuous glucose monitor and insulin pump, at ADA 2025. Fasikl’s Felix NeuroAI Wristband became the first FDA-cleared neuromodulation wearable for essential tremor. U.S. HHS Secretary RFK Jr. launched the MAHA initiative for nationwide wearable adoption.
7 July 2025
···
1 2 3

Stock Market Today

  • Shenzhen Creality 3D Technology Shares Rise 6.2%; Valuation Viewed as Overpriced
    June 8, 2026, 3:10 PM EDT. Shenzhen Creality 3D Technology (SEHK:3388) shares jumped 6.2% to HK$22.2, reversing a 2.6% year-to-date decline. Despite 36.7% revenue growth to CN¥3,127.04 million, the company reported a net loss of CN¥182.561 million, with a negative 16.94% return on equity. Valued around HK$10.36 billion, the firm's price-to-sales ratio (P/S) stands at 2.9x, notably above the Asian tech sector average of 1.7x, suggesting investors price in growth despite losses. Limited valuation crosschecks leave the high P/S as a key indicator. Heavy overseas market reliance and ongoing losses may challenge the premium valuation. Investors are urged to consider alternative robotics and automation stocks with lower multiples.

Latest articles

Nu Shares Drop, $1 Billion Buyback Doesn’t Ease Market

Nu Shares Drop, $1 Billion Buyback Doesn’t Ease Market

8 June 2026
Nu Holdings shares slid 3.1% to $11.60 as investors weighed CFO transition risks and rising credit costs, erasing last week’s 4.1% buyback-driven bounce; BofA downgraded the stock to Underperform with a $10 target, citing uncertainty from Lago’s exit, while Nu’s $1B buyback failed to stem a 10.7% weekly drop and 30.7% year-to-date decline, leaving shares just above their 52-week low.
Inno Holdings Soared Nearly 20 Times—AI Deal Includes a Caveat

Inno Holdings Soared Nearly 20 Times—AI Deal Includes a Caveat

8 June 2026
Inno Holdings shares soared twentyfold to $20.97 after announcing a $3 million AI sales agent deal for its used mobile phone business, but investor risks remain with a recent $60 million at-the-market stock program and ongoing going-concern warnings in filings, as the project is still in early development and not yet commercially launched.
Emirates Cuts A380 Flights, Raising Concerns Over Summer Airfare

Emirates Cuts A380 Flights, Raising Concerns Over Summer Airfare

8 June 2026
Emirates slashed June A380 flights on 10 major routes as soaring fuel costs and Middle East airspace disruption forced airlines to cut capacity, prompting IATA to halve its 2026 global profit forecast to $23 billion from $41 billion, with industry-wide seat reductions and rising fares expected as carriers struggle to absorb shocks during peak travel.
Wall Street Watches Microsoft’s $37 Billion AI Bet

Wall Street Watches Microsoft’s $37 Billion AI Bet

8 June 2026
Microsoft shares fell 1.5% to $410.30 as investors weighed bullish analyst calls and NHS England’s Copilot rollout against concerns that surging AI revenue—now at a $37 billion run rate—may not outpace rising costs and margin pressure from heavy infrastructure investment.
Cerebras shares jump as Wall Street eyes AI chipmaker’s Nvidia bid

Cerebras shares jump as Wall Street eyes AI chipmaker’s Nvidia bid

8 June 2026
Cerebras shares soared about 20% to $241.44 after Wall Street analysts initiated coverage post-IPO, citing rapid demand for fast AI inference and partnerships with OpenAI and AWS; Needham set a $300 price target, while the average analyst forecast reached $295, as chip stocks broadly rebounded and the PHLX Semiconductor Index jumped over 6%.
Go toTop